Literature DB >> 14615740

Acute and chronic inflammation in pediatric patients receiving hemodialysis.

Stuart L Goldstein1, Helen Currier, Lynne Watters, James M Hempe, Rita D Sheth, Douglas Silverstein.   

Abstract

OBJECTIVES: To assess chronic and acute inflammation in children receiving maintenance hemodialysis. STUDY
DESIGN: To assess markers of acute inflammation, serum levels (ELISA) of the cytokines tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta, IL-10, and IL-6, 3 to 5 mL of serum was obtained from 13 pediatric patients (mean patient weight, 37.0+/-15.2 kg; mean age, 14.6+/-4.6 years) before and 30 minutes and 24 hours after a routine midweek hemodialysis treatment session. Chronic inflammation was assessed by serum C-reactive protein (CRP) levels.
RESULTS: Early-response cytokines TNF-alpha at 30 minutes (5.84+/-0.94 to 9.67+/-0.92 pg/mL; P=.002) and 24 hours (5.84+/-0.94 to 9.54+/-1.05 pg/mL; P=.008) and IL-1beta at 30 minutes (17.19+/-2.00 to 26.17+/-1.12 pg/mL; P=.001) and 24 hours (17.19+/-2.00 to 23.01+/-1.13 pg/mL; P=.02) increased significantly after hemodialysis. Later-response cytokines IL-10 and IL-6 activation was not significant. CRP levels were elevated in 10 of 13 patients (mean, 14.7+/-9.5mg/L; range, 7.2-38.8 mg/L) and correlated with dialysis vintage. Baseline IL-6 and IL-10 levels correlated with dialysis vintage and correlated negatively with eqKt/V.
CONCLUSIONS: We observed a chronic inflammatory state in pediatric hemodialysis patients not related to the hemodialysis treatment but rather dialysis vintage and hemodialysis adequacy. We suggest that either more frequent dialysis or enhanced cytokine clearance may ameliorate the chronic inflammatory state observed in pediatric patients receiving hemodialysis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14615740     DOI: 10.1067/S0022-3476(03)00534-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  25 in total

1.  Intensified and daily hemodialysis in children might improve statural growth.

Authors:  Michel Fischbach; Joëlle Terzic; Soraya Menouer; Céline Dheu; Sylvie Soskin; Agnès Helmstetter; Marie-Claire Burger
Journal:  Pediatr Nephrol       Date:  2006-08-29       Impact factor: 3.714

2.  Correlates of resistin in children with chronic kidney disease: the chronic kidney disease in children cohort.

Authors:  Edward Nehus; Susan Furth; Bradley Warady; Mark Mitsnefes
Journal:  J Pediatr       Date:  2012-03-14       Impact factor: 4.406

Review 3.  Cardiovascular complications in pediatric end-stage renal disease.

Authors:  Rulan S Parekh; Samuel S Gidding
Journal:  Pediatr Nephrol       Date:  2004-12-15       Impact factor: 3.714

Review 4.  Cardiovascular disease in children with chronic kidney disease.

Authors:  Mark M Mitsnefes
Journal:  J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 10.121

Review 5.  Cardiovascular complications in children with chronic kidney disease.

Authors:  Rukshana Shroff; Donald J Weaver; Mark M Mitsnefes
Journal:  Nat Rev Nephrol       Date:  2011-09-13       Impact factor: 28.314

6.  Frequent hemodialysis with NxStage system in pediatric patients receiving maintenance hemodialysis.

Authors:  Stuart L Goldstein; Douglas M Silverstein; Jocelyn C Leung; Daniel I Feig; Beth Soletsky; Cathy Knight; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2007-11-08       Impact factor: 3.714

7.  Dimethylarginines and inflammation markers in patients with chronic kidney disease undergoing dialysis.

Authors:  Yildiz Oner-Iyidogan; Pernur Oner; Hikmet Kocak; Figen Gurdol; Seldag Bekpinar; Yesim Unlucerci; Yasar Caliskan; Pinar Cetinalp-Demircan; Taner Kocak; Aydin Turkmen
Journal:  Clin Exp Med       Date:  2009-02-24       Impact factor: 3.984

8.  Serum albumin level and risk for mortality and hospitalization in adolescents on hemodialysis.

Authors:  Sandra Amaral; Wenke Hwang; Barbara Fivush; Alicia Neu; Diane Frankenfield; Susan Furth
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-20       Impact factor: 8.237

Review 9.  Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management.

Authors:  Amy C Wilson; Mark M Mitsnefes
Journal:  Am J Kidney Dis       Date:  2009-08       Impact factor: 8.860

Review 10.  Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease.

Authors:  Douglas M Silverstein
Journal:  Pediatr Nephrol       Date:  2008-12-13       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.